OnKure Therapeutics Inc.

OKUR | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.10

+$0.04 (+1.31%)

At close: Sep 22, 2026, 4:00 PM ET

$3.10

$0 (0.00%)

After-hours: Sep 22, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $123.92M

Enterprise Value $-51.54M

Beta 0.30

Average Volume 255.73K

Shares Outstanding (Diluted) 49.87M

Shares Change YoY 269.15%

Institutional Ownership N/A

Exchange NASDAQ

ISIN US68277Q1058

Price Performance

Price Change 1M -22.5%

Price Change 3M -27.1%

Price Change 6M -23.5%

Price Change YTD 3.4%

Price Change 1Y 17.2%

Price Change 3Y -96.0%

Price Change 5Y -96.5%

1M CAGR (ann.) -26.1%

1Y CAGR (ann.) 23.4%

5Y CAGR (ann.) -49.4%

All-Time CAGR -51.0%

Valuation

PE Ratio -0.87

Forward PE N/A

PEG Ratio -0.03

Forward PEG 0.05

PS Ratio N/A

Forward PS 185.90

PB Ratio 0.72

P/FCF Ratio -2.59

P/Adj. FCF Ratio -2.08

P/OCF Ratio -3.19

EV/Sales N/A

EV/EBIT 0.88

EV/EBITDA 0.89

EV/FCF 1.08

Earnings Yield -114.4%

FCF Yield -38.6%

Adj. FCF Yield -48.1%

Financial Health

Net Cash $176.39M

Total Debt $926K

Cash & Short-Term Investments $176.39M

Total Assets $179.35M

Current Ratio 26.75

Quick Ratio 26.75

Debt / Equity Ratio 0.01

Debt / EBITDA -0.02

Debt / FCF -0.02

OCF / Debt -51.66

Interest Coverage -7,767.50

Altman Z-Score 8.42

Piotroski F-Score 3

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -24.7%

Returns

Return on Assets -32.7%

Return on Equity -49.0%

Return on Invested Capital -35.9%

Return on Capital Employed -36.0%

Return on Tangible Assets -32.7%

Historical Growth (CAGR)

Revenue CAGR 3Y N/A

Revenue CAGR 5Y N/A

Revenue CAGR 10Y N/A

EPS CAGR 3Y -23.8%

EPS CAGR 5Y 47.4%

EPS CAGR 10Y N/A

FCF CAGR 3Y -23.9%

FCF CAGR 5Y -12.4%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 2

EPS Growth Next 3Y 22.2%

Revenue Growth Next 3Y N/A

Earnings Date Nov 4, 2026

EPS Estimate (next Q) -$0.36

EPS Growth Est (next Q) -67.0%

Revenue Est (next Q) $166.67K

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $14

Price Target Upside 357.5%

Cash Flow

Operating Cash Flow $-47.84M

Free Cash Flow $-47.86M

Adj. Free Cash Flow $-59.67M

FCF Per Share -$0.96

OCF Per Share -$0.96

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-203K

Operating Income $-62.14M

EBITDA $-58.09M

Net Income $-58.71M

EPS (Diluted) -$3.50

Revenue / Employee N/A

Profit / Employee $-1.3M

Employees 45